RAP is finally gaining traction in the acute respiratory diagnosis for ResAppDx and a well established pharmacy with link to big pharmacy Johnson & Johnson are doing a paid pilot for use of ResAppDx in chronic respiratory management......I honestly don't think you have ever been a holder.
- Forums
- ASX - By Stock
- RAP
- Ann: Trading Halt
Ann: Trading Halt, page-164
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online